Founder of Magellan Life Sciences® Pvt. Ltd., Abhiram received his B.Tech from Anna University, Chennai and a Ph.D in Biology from Syracuse University, USA. As an Evelyn J. Neitzer research fellow at Stanford University, he pioneered the development of the BacMam Protein Expression platform for structural biology applications. This platform was. instrumental in the structure determination efforts of numerous high value membrane protein drug targets. He is the recipient of a Marie Curie European fellowship from the European Union for technology transfer of the Bacmam platform into Ireland.. Dr. Dukkipati has worked in collaboration with several multinational pharma companies on the structure determination efforts of their proprietary protein targets. He is a co-author of several high impact peer reviewed publications and a speaker at several international conferences.. Dr. Dukkipati heads the scientific research team and is responsible for identifying novel opportunities in the field of life sciences including vaccines, therapeutics and recombinant food products. He is actively involved in day to day scientific affairs of the company's overall scientific vision, business and growth strategies.
